C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-65.34M
↓ 12% below average
Average (6y)
$-58.12M
Historical baseline
Range
High:$54.27M
Low:$-111.44M
CAGR
+22.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-65.34M | +39.8% |
| 2023 | $-108.55M | +2.6% |
| 2022 | $-111.44M | -26.3% |
| 2021 | $-88.24M | -30.0% |
| 2020 | $-67.90M | -225.1% |
| 2019 | $54.27M | +375.9% |
| 2018 | $-19.67M | - |